Urinary concentrations of ethyl glucuronide and ethyl sulfate as thresholds to determine potential ethanol-induced alteration of steroid profiles

Drug Testing and Analysis

Volumn 3, Issue 11-12, 2011, Pages 851-856

  Thieme, D ^a   Grosse J ^a   Keller, L ^b   Graw, M ^b  

^a Institute of Doping Analysis   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Doping analysis; Ethylglucuronide; Steroid profile; Testosterone epitestosterone ratio

Indexed keywords

SULFUR COMPOUNDS;

DOPING ANALYSIS; ENDOGENOUS STEROIDS; ETHYL GLUCURONIDE; ETHYL SULFATE; ETHYLGLUCURONIDE; ETIOCHOLANOLONE; STEROID PROFILE; TESTOSTERONE; TESTOSTERONE/EPITESTOSTERONE RATIO; URINARY METABOLITES;

ETHANOL;

ALCOHOL; ETHYL GLUCURONIDE; ETHYL SULFATE; STEROID; SULFATE; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; BIOTRANSFORMATION; DRUG ABUSE; FEMALE; GENDER; HUMAN; KIDNEY CONCENTRATING CAPACITY; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL;

EID: 84855209034     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.396     Document Type: Article

References (23)

1. J. Cami, M. Farre, M. L. Gonzalez, J. Segura, R. de la Torre Recent Dev. Alcohol. 1998, 14, 437.
2. S. W. Toennes, K. Schneider, G. F. Kauert, C. Wunder, M. R. Moeller, E. L. Theunissen, J. G. Ramaekers Anal. Bioanal. Chem. 2011, 400, 145.
3. S. H. Andersson, T. Cronholm, J. Sjovall J. Steroid Biochem. 1986, 24, 1193.
4. O. Falk, E. Palonek, I. Bjorkhem Clin. Chem. 1988, 34, 1462.
5. K. W. Chung Toxicology 1990, 62, 285.
6. T. Karila, V. Kosunen, A. Leinonen, R. Tahtela, T. Seppala J. Chromatogr. B 1996, 687, 109.
7. T. Sarkola, C. J. Eriksson Alcohol. Clin. Exp. Res. 2003, 27, 682.
8. H. Geyer, U. Mareck, N. Haenelt, W. Schänzer, in Recent Advances in Doping Analysis, vol 17, (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ), Sportverlag Strauß: Köln, 2009, pp. 261.
9. J. Grosse, P. Anielski, H. Sachs, D. Thieme Drug Test. Analysis 2009, 1, 526.
10. U. Mareck-Engelke, H. Geyer, U. Schindler, U. Flenker, R. Iffland, M. Donike, in Recent advances in doping analysis, vol 3, (Eds: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke ). Sport und Buch Strauß: Köln, 1996, pp. 143.
11. WADA. Available at: [01 August 2011]
12. P. E. Sottas, C. Saudan, C. Schweizer, N. Baume, P. Mangin, M. Saugy Forensic Sci. Int. 2008, 174, 166.
13. R. Aguilera, M. Becchi, H. Casabianca, C. K. Hatton, D. H. Catlin, B. Starcevic, H. G. Pope Jr. J. Mass Spectrom. 1996, 31, 169.
14. W. Weinmann, P. Schaefer, A. Thierauf, A. Schreiber, F. M. Wurst, J. Am. Soc. Mass Spectrom. 2004, 15, 188.
15. J. C. Kissack, J. Bishop, A. L. Roper, Pharmacotherapy 2008, 28, 769.
16. R. B. Palmer Semin. Diagn. Pathol. 2009, 26, 18.
17. C. C. Halter, A. Laengin, A. Al-Ahmad, F. M. Wurst, W. Weinmann, K. Kuemmerer, Forensic Sci. Int. 2009, 186, 52.
18. F. M. Wurst, S. Dresen, J. P. Allen, G. Wiesbeck, M. Graf, W. Weinmann, Addiction 2006, 101, 204.
19. H. Geyer, W. Schanzer, U. Mareck-Engelke, E. Nolteernsting, G. Opfermann, (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ). Cologne, 1997, pp. 99.
20. N. Dunnett, K. J. Kimber J. Forensic Sci. Soc. 1968, 8, 15.
21. C. Ayotte Handb Exp Pharmacol, 77.
22. J. J. Schulze, J. Lundmark, M. Garle, I. Skilving, L. Ekstrom, A. Rane J. Clin. Endocrinol. Metab. 2008, 93, 2500.
23. W. Wilson, 3rd, F. Pardo-Manuel de Villena, B. D. Lyn-Cook, P. K. Chatterjee, T. A. Bell, D. A. Detwiler, R. C. Gilmore, I. C. Valladeras, C. C. Wright, D. W. Threadgill, D. J. Grant Genomics 2004, 84, 707.